BIOLASE Inc (NASDAQ:BIOL)
| 0.292 BATS BZX Real-Time Price As of 10:40am ET |  -0.0114 / -3.76%Today’s Change | 0.21 Today|||52-Week Range 0.96 | -47.17% Year-to-Date |
Latest BIOL News | Press Releases
| Here's Why You Should Hold on to Stryker (SYK) Stock Now Oct 13 / Zacks.com - Paid Partner Content | Masimo Unveils New Wearable Wireless Continuous Thermometer Oct 08 / Zacks.com - Paid Partner Content |
| Ecolab Introduces New Automated Precision Dispensing System Oct 09 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.30 |
| Today’s open | 0.32 |
| Day’s range | 0.29 - 0.30 |
| Volume | 26,427 |
| Average volume (3 months) | 6,195,760 |
| Market cap | $28.6M |
Data as of 10:40am ET, 10/20/2020
Growth & Valuation
| Earnings growth (last year) | +26.36% |
| Earnings growth (this year) | +54.98% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -18.10% |
| P/E ratio | NM |
| Price/Sales | 0.34 |
| Price/Book | 25.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PDEXPro-Dex Inc | +3.80 | +13.92% |
| MLSSMilestone Scientific... | +0.09 | +5.33% |
| ---- | ||
| XRAYDENTSPLY SIRONA Inc | +0.29 | +0.65% |
Data as of 10:31am ET, 10/20/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $37.8M |
| Annual profit (last year) | -$17.9M |
| Net profit margin | -47.24% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
